TechnoDerma, VivaVision, Arthrosi, Apeiron Therapeutics and AceLink made solid progress in R&D; Full Circles published breakthrough results; Antag successfully completed financing.
Ian Delaney, Chair of the Board commented, "We are delighted to have a highly respected industry veteran like Menes join the Board as we complete this unique strategic combination. His extensive ...